Levin Capital Strategies’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,453
Closed -$328K 265
2018
Q4
$328K Sell
2,453
-3,390
-58% -$556K 0.01% 189
2018
Q3
$1.11M Sell
5,843
-3,692
-39% -$678K 0.02% 134
2018
Q2
$1.59M Buy
9,535
+500
+6% +$80.3K 0.03% 111
2018
Q1
$1.52M Sell
9,035
-645,138
-99% -$108M 0.03% 122
2017
Q4
$107M Buy
654,173
+202,643
+45% +$36.4M 1.81% 21
2017
Q3
$92.5M Buy
451,530
+329,450
+270% +$76.6M 1.57% 23
2017
Q2
$29.7M Sell
122,080
-1,596
-1% -$375K 0.52% 37
2017
Q1
$29.5M Sell
123,676
-28,997
-19% -$6.75M 0.53% 42
2016
Q4
$32.1M Sell
152,673
-137,120
-47% -$28.4M 0.55% 41
2016
Q3
$66.7K Sell
289,793
-30,488
-10% -$7.45M 0.98% 26
2016
Q2
$74M Buy
320,281
+165,057
+106% +$38.1M 1.33% 23
2016
Q1
$41.6M Buy
155,224
+124,693
+408% +$35.7M 0.75% 37
2015
Q4
$9.54M Sell
30,531
-433,546
-93% -$129M 0.17% 87
2015
Q3
$126M Buy
464,077
+2,541
+0.6% +$781K 2.15% 16
2015
Q2
$140M Sell
461,536
-81,466
-15% -$24.3M 2.07% 15
2015
Q1
$162M Buy
543,002
+34,020
+7% +$9.7M 2.42% 12
2014
Q4
$131M Sell
508,982
-42,406
-8% -$10.6M 1.98% 15
2014
Q3
$133M Buy
551,388
+537,111
+3,762% +$120M 2.02% 13
2014
Q2
$3.19M Buy
+14,277
New +$2.96M 0.05% 161

Other funds holding AGN

Levin Capital Strategies's AGN Position: Q1 2019 in Review

Levin Capital Strategies sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,453 shares — an estimated $328K sold.

Levin Capital Strategies first reported a position in AGN in Q2 2014 and held it in 19 quarters. The position peaked at $162M in Q1 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Levin Capital Strategies reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Levin Capital Strategies sold 2,453 Allergan plc shares in Q1 2019, an estimated $328K.
  • Levin Capital Strategies first reported a position in Allergan plc in Q2 2014 and held it in 19 quarters.
  • Levin Capital Strategies's Allergan plc position peaked at $162M in Q1 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Levin Capital Strategies's 13F filing for Q1 2019, filed 13 May 2019.